Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
Saved in:
| Title: | Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. |
|---|---|
| Authors: | Busnadiego, Idoia1 (AUTHOR), Abela, Irene A.1,2 (AUTHOR), Frey, Pascal M.2,3 (AUTHOR), Hofmaenner, Daniel A.4 (AUTHOR), Scheier, Thomas C.2 (AUTHOR), Schuepbach, Reto A.4 (AUTHOR), Buehler, Philipp K.4 (AUTHOR), Brugger, Silvio D.2 (AUTHOR) silvio.brugger@usz.ch, Hale, Benjamin G.1 (AUTHOR) silvio.brugger@usz.ch |
| Source: | PLoS Biology. 7/5/2022, Vol. 20 Issue 7, p1-16. 16p. 3 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
